Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab

BACKGROUND: Real-world (RW) evidence on nivolumab in pretreated patients with non-small cell lung cancer (NSCLC) by matching data from administrative health flows (AHFs) and clinical records (CRs) may close the gap between pivotal trials and clinical practice. METHODS: This multicenter RW study aims...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasello, Giulia, Lorenzi, Martina, Calvetti, Lorenzo, Oliani, Cristina, Pavan, Alberto, Favaretto, Adolfo, Palazzolo, Giovanni, Giovanis, Petros, Zustovich, Fable, Bonetti, Andrea, Bernardi, Daniele, Mandarà, Marta, Aprile, Giuseppe, Crivellaro, Giovanna, Sinigaglia, Giusy, Tognazzo, Sandro, Morandi, Paolo, Bortolami, Alberto, Marino, Valentina, Bonanno, Laura, Guarneri, Valentina, Conte, PierFranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
European Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177098/
https://www.ncbi.nlm.nih.gov/pubmed/35429394
http://dx.doi.org/10.1093/oncolo/oyac051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177098/
https://www.ncbi.nlm.nih.gov/pubmed/35429394
http://dx.doi.org/10.1093/oncolo/oyac051

Ejemplares similares